Fig. 1From: High-dose intravenous glucocorticoid induces hyperamylasemia: a case seriesAMY fluctuations of the four cases and the corresponding course of disease. The four cases started to use high-dose mPSL on the 3rd day, 6th day, 8th day, and 9th day of the disease course. AMY elevation was noted on the 19th day, 9th day, 14th day, and 13th day, respectively. AMY peak appeared on day 22, day 17, day 18, and day 34, respectively. Amylase was monitored for five consecutive days in cases 1 and 2 and weekly in cases 3 and 4Back to article page